Our site in Stevenage, UK

Our dedicated, state-of-the-art advanced therapy CDMO facility in Stevenage, UK serves as the Center of Excellence for the development and cGMP manufacturing of cutting-edge viral vector therapeutics for our clients and their patients. As a true partner to biotech and pharmaceutical companies, we enable our clients to transform their ideas into real advanced therapy products with the potential to treat and even cure patients with serious, rare or previously untreated diseases. 

At Rentschler Biopharma, we recognize the importance of flexibility, allowing you to customize your viral vector program according to your unique needs, while achieving critical milestones. Our collaborative approach ensures we work closely with you to develop bespoke solutions that align with your goals and strategy, handling your projects as if they were our own.